Methylene blue: The Trojan horse

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 28, Issue 2, 2014, Pages

  Weiner, Menachem M ^a   Fischer, Gregory W ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENE BLUE;

BLOOD PRESSURE; CIRCULATION; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; LETTER; LITERATURE; LONG TERM CARE; MORBIDITY; PRIORITY JOURNAL; PROPENSITY SCORE; PROPHYLAXIS; TREATMENT OUTCOME; VASOPLEGIA; META ANALYSIS;

HUMANS; HYPOTENSION; METHYLENE BLUE; VASOCONSTRICTOR AGENTS;

EID: 84896331776     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.12.011     Document Type: Letter

References (4)

1. G. Landoni, L. Pasin, and M. Umbrello et al. Methylene blue as a vasopressor: A meta-analysis of randomised trials Crit Care Resusc 15 2013 42 48
2. M.M. Weiner, H.M. Lin, and D. Danforth et al. Methylene Blue is Associated with Poor Outcomes in Vasoplegic Shock J Cardiothorac Vasc Anesth 27 2013 1233 1238
3. H. Riha, and J.G. Augoustides Pro: Methylene blue as a rescue therapy for vasoplegia after cardiac surgery J Cardiothorac Vasc Anesth 25 2011 736 738
4. R.G. Leyh, T. Kofidis, and M. Strüber et al. Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 125 2003 1426 1431